German HTA Negative On Benefits Of First Ever Peanut Allergy Treatment
Executive Summary
The decision by IQWiG could have an impact on how Palforzia is priced if the findings are upheld.
You may also be interested in...
England’s NICE Okays First Ever Peanut Allergy Treatment Palforzia
Aimmune Therapeutics secures agreement with NHS for “step change” in treating peanut allergy.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.